« Previous
Next »
Titles
- U.S. Department of Health and Human services overdose prevention strategy1
- Uncomplicated urinary tract infections: developing drugs for treatment1
- Unique device identification: convenience kits : guidance for industry and Food and Drug Administration staff1
- Unique device identification: direct marking of devices : guidance for Industry and Food and Drug administration staff1
- Unique device identification: policy regarding compliance dates for class I and unclassified devices : immediately in effect guidance for industry and Food and Drug Administration staff1
- Unique device identification: policy regarding compliance dates for class I and unclassified devices and certain devices requiring direct marking : immediately in effect guidance for industry and Food and Drug Administration staff1
- Use of International Standard ISO 10993-1: "Biological evaluation of medical devices - part 1 : evaluation and testing within a risk management process" : guidance for industry and Food and Drug Administration staff1
- Use of electronic health record data in clinical investigations1
- Use of public human genetic variant databases to support clinical validity for genetic and genomic-based in vitro diagnostics: guidance for stakeholders and Food and Drug Administration staff1
- Use of real-world evidence to support regulatory decision-making for medical devices: guidance for industry and Food and Drug Administration staff1
- Use of serological tests to reduce the risk of transfusion-transmitted human T-lymphotropic virus types I and II (HTLV-I/II)1
- Use of serological tests to reduce the risk of transmission of Trypanosoma cruzi infection in blood and blood components1
- Utilizing animal studies to evaluate organ preservation devices: guidance for industry and Food and Drug Administration staff1